JP2005511482A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511482A5
JP2005511482A5 JP2002586732A JP2002586732A JP2005511482A5 JP 2005511482 A5 JP2005511482 A5 JP 2005511482A5 JP 2002586732 A JP2002586732 A JP 2002586732A JP 2002586732 A JP2002586732 A JP 2002586732A JP 2005511482 A5 JP2005511482 A5 JP 2005511482A5
Authority
JP
Japan
Prior art keywords
group
protonated compound
antimicrobial composition
composition
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002586732A
Other languages
English (en)
Japanese (ja)
Other versions
JP4347573B2 (ja
JP2005511482A (ja
Filing date
Publication date
Priority claimed from US09/847,654 external-priority patent/US20020032164A1/en
Application filed filed Critical
Publication of JP2005511482A publication Critical patent/JP2005511482A/ja
Publication of JP2005511482A5 publication Critical patent/JP2005511482A5/ja
Application granted granted Critical
Publication of JP4347573B2 publication Critical patent/JP4347573B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002586732A 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物 Expired - Fee Related JP4347573B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/847,654 US20020032164A1 (en) 1998-12-30 2001-05-03 Antimicrobial compounds and methods for their use
PCT/US2002/013910 WO2002089581A1 (en) 2001-05-03 2002-05-03 Antimicrobial compounds and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009120362A Division JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2005511482A JP2005511482A (ja) 2005-04-28
JP2005511482A5 true JP2005511482A5 (enExample) 2005-12-22
JP4347573B2 JP4347573B2 (ja) 2009-10-21

Family

ID=25301163

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2002586732A Expired - Fee Related JP4347573B2 (ja) 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物
JP2009120362A Expired - Fee Related JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法
JP2013210031A Expired - Fee Related JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法
JP2015219286A Expired - Fee Related JP6097372B2 (ja) 2001-05-03 2015-11-09 抗菌化合物およびそれらの使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2009120362A Expired - Fee Related JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法
JP2013210031A Expired - Fee Related JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法
JP2015219286A Expired - Fee Related JP6097372B2 (ja) 2001-05-03 2015-11-09 抗菌化合物およびそれらの使用方法

Country Status (10)

Country Link
US (2) US20020032164A1 (enExample)
EP (2) EP1389909B1 (enExample)
JP (4) JP4347573B2 (enExample)
AU (1) AU2002305336B2 (enExample)
CA (2) CA2445381C (enExample)
CY (1) CY1116784T1 (enExample)
DK (1) DK2311466T3 (enExample)
ES (1) ES2549766T3 (enExample)
PT (1) PT2311466E (enExample)
WO (1) WO2002089581A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
EP2351765A3 (en) * 2001-07-10 2012-02-22 Lakewood-Amedex, Inc Oligonucleotide-containing pharmacological compositions and their use
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
EP1680414A4 (en) * 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED INDAZOLE-O-GLUCOSIDE
ES2402098T5 (es) * 2003-08-01 2021-06-09 Mitsubishi Tanabe Pharma Corp Compuestos novedosos que tienen actividad inhibidora frente a transportador dependiente de sodio
TW200727785A (en) * 2005-11-25 2007-08-01 Maruishi Pharma Gel composition for antibacterial sterilization
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
WO2008135085A1 (en) * 2007-05-04 2008-11-13 Symrise Gmbh & Co. Kg Synergistic active preparations comprising 1,2-decanediol and further antimicrobial active compounds
NO2200606T3 (enExample) * 2007-09-10 2018-03-24
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
GB2460445B (en) * 2008-05-30 2012-07-11 Vernolix Ltd Treatment of ringworm
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) * 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN102482250B (zh) 2009-07-10 2014-11-19 詹森药业有限公司 1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯的结晶方法
WO2011047113A1 (en) * 2009-10-14 2011-04-21 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
JP6227406B2 (ja) 2010-05-11 2017-11-08 ヤンセン ファーマシューティカ エヌ．ベー． ＳＧＬＴの阻害剤としての１−（β−Ｄ−グルコピラノシル）−２−チエニル−メチルベンゼン誘導体を含有する医薬製剤
WO2012140120A1 (en) 2011-04-13 2012-10-18 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
US11377468B2 (en) 2017-03-10 2022-07-05 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
ES2987873T3 (es) 2017-03-10 2024-11-18 Lakewood Amedex Inc Compuestos antimicrobianos, composiciones y usos de los mismos
EP3638251B1 (en) 2017-06-12 2024-03-06 Lakewood Amedex, Inc. Bisphosphocin gel formulations and uses thereof
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
SG11202103180QA (en) 2018-10-17 2021-05-28 Lakewood Amedex Inc Methods and compositions for treating oral mucositis
CZ2019769A3 (cs) * 2019-12-12 2021-09-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. Lipofosfonoxiny třetí generace, jejich příprava a použití
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
KR20220009630A (ko) * 2020-07-16 2022-01-25 정준영 플라즈마를 이용한 마스크 폐기 처리기
CN115448967A (zh) * 2022-09-26 2022-12-09 泽同医药科技(南通)有限公司 一种吩噁嗪半乳烯糖碳苷化合物及其合成方法
WO2025179296A1 (en) * 2024-02-22 2025-08-28 Lakewood Amedex, Inc. Crystalline forms of nu-3 and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
DE2916318A1 (de) * 1979-04-23 1980-11-06 Hoechst Ag Waesserige desinfektionsloesung
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4908209A (en) * 1983-08-16 1990-03-13 Interface, Inc. Biocidal delivery system of phosphate ester and method of preparation thereof
JPS60209077A (ja) * 1984-03-27 1985-10-21 竹本油脂株式会社 繊維処理用油剤及び該油剤による合成繊維糸の処理方法
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
DE3542516A1 (de) 1985-12-02 1987-06-04 Henkel Kgaa Desinfektionsmittel
AU2426688A (en) * 1987-08-03 1989-03-01 Interface Research Corporation Microbiocidal cleansing of disinfectant formulations and preparation therof
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
ZA902710B (en) 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
EP0622373A1 (en) * 1990-12-07 1994-11-02 The Upjohn Company Phosphonic acid derivatives useful as anti-inflammatory agents
US5811568A (en) * 1992-10-08 1998-09-22 Shaman Pharmaceuticals, Inc. Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
US5681829A (en) * 1992-10-08 1997-10-28 Shaman Pharmaceuticals, Inc. Class of phosphocholine derivatives having antifungal activity
JPH08502298A (ja) * 1992-10-08 1996-03-12 シェイマン ファーマシューティカル，インコーポレーテッド 抗真菌活性をもつ新規クラスのホスホコリン誘導体
DE4333385C2 (de) 1993-09-30 1997-01-30 Friedrich A Spruegel Flächendesinfektions- und Reinigungsmittel
FR2718022B1 (fr) 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2727289B1 (fr) * 1994-11-30 1999-03-05 Derives Resiniques Terpenique Composition desinfectante comprenant au moins un alcool terpenique et au moins un tensio-actif acide bactericide, et utilisation de tels tensio-actifs
CA2238484A1 (en) * 1995-11-28 1997-06-05 Michael D. Wider Antimicrobial composition and methods of use therefor
US5843998A (en) 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6211349B1 (en) * 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US6610314B2 (en) * 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations

Similar Documents

Publication Publication Date Title
JP2005511482A5 (enExample)
JP2009179639A5 (enExample)
JP2002502874A5 (enExample)
JP2002539181A5 (enExample)
JP2005523922A5 (enExample)
JP2013540786A5 (enExample)
JP2002540208A5 (enExample)
KR970014765A (ko) 신경보호제를 이용한 이명의 치료
JP2004501940A5 (enExample)
JP2005507004A5 (enExample)
JP2003503449A5 (enExample)
JP2009520695A5 (enExample)
JP2004529953A5 (enExample)
JP2004525178A5 (enExample)
BR1100212A (pt) Composto pesticida de solo; processo de preparação de um composto pesticida; composição inseticida; uso de um composto; e processo de combate de pestes de insetos originários do solo.
JP2005519989A5 (enExample)
JP2005516898A5 (enExample)
DE69929362D1 (de) verwendung von 1,4-benzothiazepinen zur Herstellung eines Medikaments ZUR BEHANDLUNG DER VORHOF-FIBRILLATION
JP2007523874A5 (enExample)
HUP9901526A2 (hu) Atorvastatin szintézis, közbenső termékei és eljárás ezek előállítására
JP2004538314A5 (enExample)
JPH1112272A5 (enExample)
RU2005101201A (ru) Аминоацетонитрилбные производные, пригодные для борьбы с паразитами
BR0113633A (pt) Compostos úteis como inseticidas, compostos úteis como acaricidas e processos para utilização e obtenção dos mesmos
JP2001233852A5 (enExample)